|
1
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: Data
from the surveillance, epidemiology, and end results program.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bian ZY, Fan QM, Li G, Xu WT and Tang TT:
Human mesenchymal stem cells promote growth of osteosarcoma:
Involvement of interleukin-6 in the interaction between human
mesenchymal stem cells and Saos-2. Cancer Sci. 101:2554–2560. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tu B, Du L, Fan QM, Tang Z and Tang TT:
STAT3 activation by IL-6 from mesenchymal stem cells promotes the
proliferation and metastasis of osteosarcoma. Cancer Lett.
325:80–88. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dieudonné FX, Marion A, Haÿ E, Marie PJ
and Modrowski D: High Wnt signaling represses the proapoptotic
proteoglycan syndecan-2 in osteosarcoma cells. Cancer Res.
70:5399–5408. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dasari S and Tchounwou PB: Cisplatin in
cancer therapy: Molecular mechanisms of action. Eur J Pharmacol.
740:364–378. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
He H, Ni J and Huang J: Molecular
mechanisms of chemoresistance in osteosarcoma (Review). Oncol Lett.
7:1352–1362. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Longley DB and Johnston PG: Molecular
mechanisms of drug resistance. J Pathol. 205:275–292. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hsieh YF, Liu GY, Lee YJ, Yang JJ, Sándor
K, Sarang Z, Bononi A, Pinton P, Tretter L, Szondy Z and Tsay GJ:
Transglutaminase 2 contributes to apoptosis induction in Jurkat T
cells by modulating Ca2+ homeostasis via cross-linking
RAP1GDS1. PLoS One. 8:e815162013. View Article : Google Scholar
|
|
9
|
Lauzier A, Charbonneau M, Paquette M,
Harper K and Dubois CM: Transglutaminase 2 cross-linking activity
is linked to invadopodia formation and cartilage breakdown in
arthritis. Arthritis Res Ther. 14:R1592012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Singer CF, Hudelist G, Walter I,
Rueckliniger E, Czerwenka K, Kubista E and Huber AV: Tissue
array-based expression of transglutaminase-2 in human breast and
ovarian cancer. Clin Exp Metastasis. 23:33–39. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Park KS, Kim HK, Lee JH, Choi YB, Park SY,
Yang SH, Kim SY and Hong KM: Transglutaminase 2 as a cisplatin
resistance marker in non-small cell lung cancer. J Cancer Res Clin
Oncol. 136:493–502. 2010. View Article : Google Scholar
|
|
12
|
Hwang JY, Mangala LS, Fok JY, Lin YG,
Merritt WM, Spannuth WA, Nick AM, Fiterman DJ, Vivas-Mejia PE,
Deavers MT, et al: Clinical and biological significance of tissue
transglutaminase in ovarian carcinoma. Cancer Res. 68:5849–5858.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang W, Li X, Han XZ, Meng FB, Wang ZX,
Zhai YQ and Zhou DS: Transglutaminase-2 is involved in cell
apoptosis of osteosarcoma cell line U2OS under hypoxia condition.
Cell Biochem Biophys. 72:283–288. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mehta K: High levels of transglutaminase
expression in doxorubicin-resistant human breast carcinoma cells.
Int J Cancer. 58:400–406. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Antonyak MA, Jansen JM, Miller AM, Ly TK,
Endo M and Cerione RA: Two isoforms of tissue transglutaminase
mediate opposing cellular fates. Proc Natl Acad Sci USA.
103:18609–18614. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔC T method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
17
|
Li S, Sun W, Wang H, Zuo D, Hua Y and Cai
Z: Research progress on the multidrug resistance mechanisms of
osteosarcoma chemotherapy and reversal. Tumour Biol. 36:1329–1338.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Holohan C, Van Schaeybroeck S, Longley DB
and Johnston PG: Cancer drug resistance: An evolving paradigm. Nat
Rev Cancer. 13:714–726. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Asada N, Tsuchiya H, Ueda Y and Tomita K:
Establishment and characterization of an acquired
cisplatin-resistant subline in a human osteosarcoma cell line.
Anticancer Res. 18:1765–1768. 1998.PubMed/NCBI
|
|
20
|
Letai AG: Diagnosing and exploiting
cancer's addiction to blocks in apoptosis. Nat Rev Cancer.
8:121–132. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhao Z, Tao L, Shen C, Liu B, Yang Z and
Tao H: Silencing of Barkor/ATG14 sensitizes osteosarcoma cells to
cisplatin-induced apoptosis. Int J Mol Med. 33:271–276. 2014.
View Article : Google Scholar :
|
|
22
|
Wang G, Rong J, Zhou Z and Duo J: Novel
gene P28GANK confers multidrug resistance by modulating the
expression of MDR-1, Bcl-2 and Bax in osteosarcoma cells. Mol Biol.
44:1010–1017. 2010. View Article : Google Scholar
|
|
23
|
Botham RC, Roth HS, Book AP, Roady PJ, Fan
TM and Hergenrother PJ: Small-molecule procaspase-3 activation
sensitizes cancer to treatment with diverse chemotherapeutics. ACS
Cent Sci. 2:545–559. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lee HJ and Lee CH: Transglutaminase-2 is
involved in expression of osteoprotegerin in MG-63 osteosarcoma
cells. Biomol Ther. 21:204–209. 2013. View Article : Google Scholar
|
|
25
|
Cao L, Petrusca DN, Satpathy M, Nakshatri
H, Petrache I and Matei D: Tissue transglutaminase protects
epithelial ovarian cancer cells from cisplatin-induced apoptosis by
promoting cell survival signaling. Carcinogenesis. 29:1893–1900.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Han JA and Park SC: Reduction of
transglutaminase 2 expression is associated with an induction of
drug sensitivity in the PC-14 human lung cancer cell line. J Cancer
Res Clin Oncol. 125:89–95. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nurminskaya MV and Belkin AM: Cellular
functions of tissue transglutaminase. Int Rev Cell Mol Biol.
294:1–97. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
He W, Sun Z and Liu Z: Silencing of TGM2
reverses epithelial to mesenchymal transition and modulates the
chemosensitivity of breast cancer to docetaxel. Exp Ther Med.
10:1413–1418. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zöllinger A, Stühmer T, Chatterjee M,
Gattenlöhner S, Haralambieva E, Müller-Hermelink HK, Andrulis M,
Greiner A, Wesemeier C, Rath JC, et al: Combined functional and
molecular analysis of tumor cell signaling defines 2 distinct
myeloma subgroups: Akt-dependent and Akt-independent multiple
myeloma. Blood. 112:3403–3411. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Peng DJ, Wang J, Zhou JY and Wu GS: Role
of the Akt/mTOR survival pathway in cisplatin resistance in ovarian
cancer cells. Biochem Biophys Res Commun. 394:600–605. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang H, Luo QF, Peng AF, Long XH, Wang TF,
Liu ZL, Zhang GM, Zhou RP, Gao S, Zhou Y, et al: Positive feedback
regulation between Akt phosphorylation and fatty acid synthase
expression in osteosarcoma. Int J Mol Med. 33:633–639. 2014.
View Article : Google Scholar
|
|
32
|
Wheeler DL, Huang S, Kruser TJ,
Nechrebecki MM, Armstrong EA, Benavente S, Gondi V, Hsu KT and
Harari PM: Mechanisms of acquired resistance to cetuximab: Role of
HER (ErbB) family members. Oncogene. 27:3944–3956. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sergina NV, Rausch M, Wang D, Blair J,
Hann B, Shokat KM and Moasser MM: Escape from HER-family tyrosine
kinase inhibitor therapy by the kinase-inactive HER3. Nature.
445:437–441. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liao YX, Zhou CH, Zeng H, Zuo DQ, Wang ZY,
Yin F, Hua YQ and Cai ZD: The role of the CXCL12-CXCR4/CXCR7 axis
in the progression and metastasis of bone sarcomas (Review). Int J
Mol Med. 32:1239–1246. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cheng DD, Zhu B, Li SJ, Yuan T, Yang QC
and Fan CY: Down-regulation of RPS9 inhibits osteosarcoma cell
growth through inactivation of MAPK signaling pathway. J Cancer.
8:2720–2728. 2017. View Article : Google Scholar : PubMed/NCBI
|
